Press release
The Intravitreal IVT Injectable Market to Witness Invigorating Trends
Retinal diseases contributing heavily to the demand growth of intravitreal (IVT) injectables
Hereditary retinal diseases is the major cause of visual loss. Macular degeneration, Diabetic Retinopathy is the important and prominent cause of blindness. According to Genentech Retinal disease report, around 11 million US population are affected with age-related macular degeneration, 7.7 million people are affected with diabetic retinopathy and around 1.1 million population are affected with retinal vein occlusions.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/25906
Anti-VEGF intravitreal (IVT) injectables medication is most likely use to treat retinal disorders. Increasing prescription of anti-VEGF anticipate the growth of the intravitreal (IVT) injectables market. Many manufacturers aims to develop drugs with anti-VEGF inhibitor, as a result leading to an increase in the demand for intravitreal (IVT) injectables.
Company Profiles:
Regeneron Pharmaceuticals, Inc.
Bausch & Lomb
Novartis AG
Allergan
Alimera Sciences
ThromboGenics, Inc.
Bristol-Myers Squibb Company
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/25906
North America to have substantial revenue growth in intravitreal (IVT) injectables Market
North America region shown to have high growth in intravitreal (IVT) injectables market. Low vision and blindness are prevailing in the region and high prescription of anti-VEGF intravitreal (IVT) injectables medication has increases the growth of intravitreal (IVT) injectables market. It is estimated that intravitreal (IVT) injectables create an incremental $ opportunity worth US$ 4,350 Mn between 2018 and 2028.
Lucentis marketed by Roche and Eylea marketed by Regeneron in the United States, are the commonly prescribed biologics use in intravitreal (IVT) injectables. Apart from this, Avastin and Macugen are also widely used in intravitreal (IVT) injectables market. The North America region holds a significant share in intravitreal (IVT) injectables among all other regions, due to the increase in prescription of retinal biologics, high healthcare facilities and availability and usage of expensive drugs.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/25906
Intravitreal (IVT) Injectables Market: Segmental Analysis
The global intravitreal (IVT) injectables market has been segmented on the basis of drug class, indication and distributional channel. On the basis of drug class, the intravitreal (IVT) injectables market has been segmented into anti-VEGF, corticosteroids, antibiotics, antivirals and antifungals. Based on indication, the intravitreal (IVT) injectables market has been segmented into diabetic retinopathy, macular degeneration, endophthalmitis, retinal vein occlusions and others.
In terms of revenue, the anti-VEGF segment is expected to have a major share in intravitreal (IVT) injectables during the forecast period as it prevents angiogenesis and also minimize the leakage of fluid that occurs due to retinal diseases.
Complete Report Details@ https://www.persistencemarketresearch.com/market-research/intravitreal-ivt-injectable-market.asp
On the basis of distributional channel, the intravitreal (IVT) injectables market has been categorized into hospital pharmacies, retail pharmacies, drug stores, mail order pharmacies and others. The hospital pharmacies is expected to have high revenue growth in intravitreal (IVT) injectables, owing to the availability of biologics and increase in prescription of anti-VEGF drugs.
Related Reports:
Generic Oncology Drugs Market - https://www.persistencemarketresearch.com/market-research/generic-oncology-drugs-market.asp
Cutaneous Fribrosis Treatment Market - https://www.persistencemarketresearch.com/market-research/cutaneous-fribrosis-treatment-market.asp
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Intravitreal IVT Injectable Market to Witness Invigorating Trends here
News-ID: 2593068 • Views: …
More Releases from Persistence Market Research
Power Quality Equipment Market Size to Reach US$54.2 Billion by 2032, Driven by …
Market Overview
The global power quality equipment market is witnessing significant growth as industries, utilities, and commercial sectors increasingly emphasize uninterrupted and reliable electricity supply. According to Persistence Market Research's projections, the market size is expected to be valued at US$35.8 billion in 2025 and is projected to reach US$54.2 billion by 2032, expanding at a CAGR of 6.1% during the forecast period. This growth is fueled by rapid industrialization, rising…
Anaerobic Adhesives Market Size to Reach US$894.5 Million by 2031, Driven by Exp …
Market Overview
The global anaerobic adhesives market is experiencing steady growth as industries increasingly adopt advanced bonding solutions that enhance durability, reliability, and performance. According to Persistence Market Research's projections, the market is estimated to rise from US$613.9 million in 2024 to US$894.5 million by 2031, expanding at a CAGR of 5.5% during the forecast period. This growth is fueled by the rising demand from sectors such as automotive, aerospace, electronics,…
Textile Coatings Market Size to Reach US$6.8 Billion by 2031, Fueled by Demand f …
Market Overview
The global textile coatings market is witnessing steady growth, driven by the rising demand for functional, durable, and performance-enhancing fabrics across industries such as automotive, construction, healthcare, and fashion. According to Persistence Market Research's projections, the market is estimated to increase from US$4.8 billion in 2024 to US$6.8 billion by 2031, expanding at a CAGR of 5.0% during the forecast period. This growth is underpinned by the increasing adoption…
Architectural LED Products Market to Reach $23.6 Bn by 2032 Driven by Energy-Eff …
The global architectural LED products market is poised for substantial expansion over the next decade. Valued at approximately USD 12.5 billion in 2025, the market is projected to reach USD 23.6 billion by 2032, reflecting a robust compound annual growth rate (CAGR) of 9.4% during the forecast period from 2025 to 2032. This growth trajectory underscores the increasing adoption of LED technologies across residential, commercial, and industrial sectors, driven by…
More Releases for IVT
Intravitreal (IVT) Injectable Market Dynamics: Driving Forces Behind Market Expa …
The healthcare sector, especially in the field of ophthalmology, is witnessing significant growth due to the rising prevalence of eye diseases and advancements in injectable drug delivery systems. One of the most important developments in the treatment of retinal diseases has been the introduction of intravitreal (IVT) injectables. These injectable therapies are used to treat a range of eye conditions, such as age-related macular degeneration (AMD), diabetic retinopathy (DR), diabetic…
Intravitreal (IVT) Injectable Market Transformative Innovations and Future Growt …
𝑰𝒏𝒕𝒓𝒐𝒅𝒖𝒄𝒕𝒊𝒐𝒏
The Intravitreal (IVT) injectable market has emerged as a pivotal segment in ocular therapeutics, driven by the increasing prevalence of retinal disorders and advancements in drug delivery technologies. Intravitreal injections, administered directly into the vitreous humor, have revolutionized the treatment of various ocular conditions such as age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO). This article explores the transformative innovations shaping the IVT injectable market…
Intravitreal (IVT) Injectable Market Size, Share, Industry, Forecast (2024-2031)
Market Overview:
The global intravitreal injectable market is growing at a CAGR of 5.8% during the forecast period of 2024-2031. Key drivers of market growth include the increasing prevalence of chronic retinal diseases, particularly cataracts, and advancements in drug development by key manufacturers to meet patient needs. However, market growth may be hindered by the risks associated with intravitreal injections.
Market Dynamics:
Growing Prevalence of Cataracts: Cataracts, which are the primary cause of…
The Intravitreal (IVT) Injectable Market To Prove Its Servility To Technological …
According to the most recent Persistence Market Research (PMR) report, the Intravitreal (IVT) Injectables Market will grow at a CAGR of 4.9% between 2022 and 2028, surpassing US$ 23,814.3 million in terms of market value.
Growing retinal diseases are expected to boost the global intravitreal injectable market at a substantial rate over the forecast period. Millions of people are affected by retinal disorders, which commonly result in vision loss or complete…
The Intravitreal IVT Injectable Market to grow on an invincible note
The Intravitreal IVT Injectable Market is expected to grow by leaps and bounds in the forecast period. Nanotechnology’s medical application is on the anvil. As such, nanomedicine is an outcome of the technology operating at the molecular, atomic, or supramolecular scale. The broad application areas of nanomedicine include sensing, imaging, diagnosis, and delivery via medical devices. This would certainly keep the healthcare vertical upgraded continuously.
Hereditary retinal diseases is the major…
Global Intravitreal (IVT) Injectables Market : Rising Allocations On analysis …
Albany, NY, 18th April : Recent research and the current scenario as well as future market potential of "Global Market Study on Intravitreal (IVT) Injectables: Chronic Retinal Conditions to Uplift Sales of Anti-VEGF IVT Injectables" globally.
Recently published report titled ‘Intravitreal (IVT) Injectables Market: Global Industry Analysis 2013 – 2017 and Forecast 2018–2028' offers a comprehensive assessment of the key dynamics pertaining to the intravitreal (IVT) injectables market. The report presents…
